Dostarlimab
Drug timelines are a Plus or Pro feature.
35 regulatory and trial events tracked for Dostarlimab, covering 2021-05-10 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas [Phase 2]